Výsledky vyhledávání - "J M, Hesselink"

Clinical evaluation of antidepressant drugs; Guidelines from authorities

Autor: J M Hesselink

Publikováno v: Acta Neuropsychiatrica. 4:57-62

SummaryFood and Drug Administration, World Health Organisation and Committee on Proprietary Medicinal Products have published guidelines with recommendations how to conduct clinical trials. The guidelines for the clinical evaluation of antidepressant

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b5238cfec59920b37eb78179a09b3ca
https://doi.org/10.1017/s0924270800034803

Zobrazit plný text záznamu

Iloperidone (Hoechst Marion Roussel Inc)

Autor: J M, Hesselink

Publikováno v: IDrugs : the investigational drugs journal. 2(6)

Iloperidone (HP-873) is a 5-HT2 antagonist from Hoechst Marion Roussel Inc in clinical trials for the treatment of schizophrenia and psychosis. In May 1996, the company announced that it had discontinued further development of the compound. This anno

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::e8a2a9852a9f3881fa3e77f5747154df
https://pubmed.ncbi.nlm.nih.gov/16127622

Zobrazit plný text záznamu

[Surfing the Internet with side effects: problems surrounding smart drugs]

Autor: J M, Hesselink

Publikováno v: Deutsche medizinische Wochenschrift (1946). 124(22)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::4044d8c96e62adc32fd06ec50722885c
https://pubmed.ncbi.nlm.nih.gov/10394352

Zobrazit plný text záznamu

Ipsapirone in the treatment of bulimia nervosa: an open pilot study

Autor: C, Geretsegger, K V, Greimel, I S, Roed, J M, Hesselink

Publikováno v: The International journal of eating disorders. 17(4)

Seventeen women who met the criteria for bulimia nervosa (DSM-III-R) were treated for 4 weeks in an open trial with ipsapirone, a partial 5-HT1A agonist. Bulimic symptoms diminished in 66.6% of the patients after only 1 week of treatment, 93.3% showe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::867f7960cded13d4ea0f6c4196e7603d
https://pubmed.ncbi.nlm.nih.gov/7620475

Zobrazit plný text záznamu

The safety and efficacy of ipsapirone vs. lorazepam in outpatients with generalized anxiety disorder (GAD): single site findings from a multicenter trial

Autor: N R, Cutler, J J, Sramek, T S, Wardle, J M, Hesselink, J K, Roeschen

Publikováno v: Psychopharmacology bulletin. 29(2)

We report the findings of a randomized, double-blind, placebo-controlled, parallel, generalized anxiety disorder (GAD) outpatient study. The purpose of the study was to compare the efficacy, safety, and tolerability of ipsapirone, an azapirone and 5-

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::067062239102db74c7c3c784a6ecbca9
https://pubmed.ncbi.nlm.nih.gov/7904761

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání